HealthEquity, Inc. (HQY) – What Are Analysts Thinking About This Stock?

HealthEquity, Inc. (NASDAQ:HQY) has received a consensus rating of “Moderate Buy” from the thirteen brokerages that are presently covering the stock, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, eleven have assigned a buy recommendation and one has given a strong buy recommendation to the company. The average 12-month price objective among brokerages that have issued a report on the stock in the last year is $113.53.

HQY has been the topic of several recent analyst reports. Citigroup reissued a “market outperform” rating on shares of HealthEquity in a research report on Friday, August 28th. Barclays raised their price objective on HealthEquity from $110.00 to $115.00 and gave the stock an “overweight” rating in a research report on Friday, September 18th. Wall Street Zen raised HealthEquity from a “hold” rating to a “buy” rating in a research note on Saturday, October 10th. Weiss Ratings raised HealthEquity from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Friday, October 16th. Finally, Raymond James Financial reiterated a “strong-buy” rating on shares of HealthEquity in a report on Thursday, September 3rd.

HealthEquity Stock Up 3.0%

HQY stock opened at $103.97 on Friday. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.99 and a quick ratio of 2.99. The firm has a market capitalization of $8.60 billion, a P/E ratio of 37.53, a P/E/G ratio of 1.59 and a beta of 0.24. HealthEquity has a 52-week low of $72.76 and a 52-week high of $107.62. The company’s 50 day simple moving average is $95.36 and its 200-day simple moving average is $91.92.

HealthEquity (NASDAQ:HQY) last released its earnings results on Thursday, August 27th. The company reported $1.24 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.19 by $0.05. The company had revenue of $350.73 million during the quarter, compared to analyst estimates of $349.22 million. HealthEquity had a return on equity of 15.33% and a net margin of 17.36%. The company’s revenue was up 95.5% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 4.660-4.730 EPS. As a group, equities research analysts anticipate that HealthEquity will post 3.93 EPS for the current year.

Insider Activity at HealthEquity

In related news, Director Adrian Dillon sold 7,632 shares of the business’s stock in a transaction that occurred on Tuesday, August 25th. The shares were sold at an average price of $104.61, for a total transaction of $798,383.52. Following the transaction, the director directly owned 62,395 shares of the company’s stock, valued at approximately $6,527,140.95. The trade was a 10.90% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 1.60% of the company’s stock.

Institutional Investors Weigh In On HealthEquity

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in HQY. Leonteq Securities AG increased its position in HealthEquity by 159.9% in the 1st quarter. Leonteq Securities AG now owns 382 shares of the company’s stock worth $32,000 after purchasing an additional 235 shares during the last quarter. Axiom Investment Management LLC purchased a new stake in shares of HealthEquity during the 1st quarter worth about $33,000. Silvant Capital Management LLC acquired a new stake in shares of HealthEquity during the 2nd quarter valued at about $35,000. Public Employees Retirement System of Ohio acquired a new stake in shares of HealthEquity during the 2nd quarter valued at about $39,000. Finally, Caitong International Asset Management Co. Ltd lifted its holdings in shares of HealthEquity by 2,476.5% during the 4th quarter. Caitong International Asset Management Co. Ltd now owns 438 shares of the company’s stock valued at $40,000 after buying an additional 421 shares during the last quarter. Hedge funds and other institutional investors own 99.55% of the company’s stock.

About HealthEquity

HealthEquity, Inc provides technology-enabled benefits administration and financial services that help employers and individuals manage tax-advantaged healthcare accounts. The company’s offerings include health savings accounts (HSAs), flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), and other consumer-directed benefits.

In addition to account administration, HealthEquity provides payment cards, investment options for eligible account holders, employee engagement tools, and digital platforms for managing healthcare benefits.